Tag: AUTL

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Verona Pharma(VRNA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.85 (USD) 05/21/2021 Weighted Valuation$6.20 (USD) Overall RatingUndervalued by 6.1% Valuation Models Multiples: $6.20 (USD) Valuation Methods …

Verona Pharma (VRNA:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.01 (USD) 04/15/2021 Weighted Valuation$5.93 (USD) Overall RatingUndervalued by 18.4% Valuation Models Comparables: $5.93 (USD) Valuation Methods …

Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Adaptimmune Therapeutics(ADAP:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.04 (USD) 04/14/2021 Weighted Valuation$5.05 (USD) Overall RatingFairly valued to slightly Undervalued by 0.3% Valuation Models Comparables: $7.73 …

Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Autolus Therapeutics(AUTL:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$40.88 (USD) 26/11/2018 Weighted Valuation$47.20 (USD) Overall RatingUndervalued by 15.5% Valuation Models Analyst Consensus: $45.00 (USD) (in …

Autolus Therapeutics (AUTL:NAS) Fundamental Valuation Report Read more »

Read More